Clinical Trials Browser

Phase 1 × Meningeal Neoplasms × Nivolumab × Clear all

NCT03025256 2026-01-08

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Phase 1 Active not recruiting

DermatologicThoracic

Uveal Melanoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Meningeal Neoplasms, Nevus

NCT05112549 2025-04-03

IT-PD1

Phase 1 Recruiting

Meningeal Neoplasms